Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Hybrid Antigenic Peptides as a Potential Trigger of Autoimmunity in Vaccine-Induced Immune Thrombotic Thrombocytopenia
FY 2023-24
Summary
My research looks into a rare condition known as Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT). VITT occurs when the immune system mistakenly attacks the body's own platelets, leading to dangerous blood clot formation. VITT has been observed at a very low frequency in the general population, particularly following immunization with adenoviral vector-based vaccines against COVID-19. A key player in VITT is PF4, a blood clotting-associated host protein, which can form complexes with a vaccine protein called hexon. In a very small proportion of the population, vaccination can trigger the formation of antibodies against PF4, leading to blood clot formation. However, the immune mechanisms that allow the production of these antibodies have currently not been elucidated. My research hypothesis proposes that immune cells process PF4 and hexon together, creating hybrid protein fragments. In a subset of the population, these fragments might confuse the immune system and induce an undesired immune response against host PF4, leading to VITT. This concept has precedence in other autoimmune disease models like Type 1 diabetes. My research involves in vitro experiments and mouse studies. Initially, we aim to identify hybrid fragments between hexon and PF4 in test tube reactions and human immune cells. Subsequently, we want to determine if synthetic hybrid fragments can induce a VITT-like reaction in mice. These experiments aim to elucidate VITT's origins and shed light on other autoimmune diseases. Future work may expand this to other viral components, broadening our understanding of autoimmune diseases arising from infections. Ultimately, this research might offer a new perspective on autoimmunity, showcasing how the immune system can confuse self and foreign proteins.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506099
Name
Hinse Olivier
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hybrid Antigenic Peptides as a Potential Trigger of Autoimmunity in Vaccine-Induced Immune Thrombotic Thrombocytopenia
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antigen Processing; Cathepsins; Enzymatic Assays; Hexon & Adenoviral Vectors/Sars-Cov-2 Vaccines; In Vivo Mice Experiments; Mass Spectrometry; Mhc Class-Ii Complexes; Microthrombi Formation; Pf4; Vaccine-Induced Immune Thrombotic Thrombocytopenia
Abstract
My research looks into a rare condition known as Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT). VITT occurs when the immune system mistakenly attacks the body's own platelets, leading to dangerous blood clot formation. VITT has been observed at a very low frequency in the general population, particularly following immunization with adenoviral vector-based vaccines against COVID-19. A key player in VITT is PF4, a blood clotting-associated host protein, which can form complexes with a vaccine protein called hexon. In a very small proportion of the population, vaccination can trigger the formation of antibodies against PF4, leading to blood clot formation. However, the immune mechanisms that allow the production of these antibodies have currently not been elucidated. My research hypothesis proposes that immune cells process PF4 and hexon together, creating hybrid protein fragments. In a subset of the population, these fragments might confuse the immune system and induce an undesired immune response against host PF4, leading to VITT. This concept has precedence in other autoimmune disease models like Type 1 diabetes. My research involves in vitro experiments and mouse studies. Initially, we aim to identify hybrid fragments between hexon and PF4 in test tube reactions and human immune cells. Subsequently, we want to determine if synthetic hybrid fragments can induce a VITT-like reaction in mice. These experiments aim to elucidate VITT's origins and shed light on other autoimmune diseases. Future work may expand this to other viral components, broadening our understanding of autoimmune diseases arising from infections. Ultimately, this research might offer a new perspective on autoimmunity, showcasing how the immune system can confuse self and foreign proteins.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hinse, Olivier
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~